Hepatic release of tumor necrosis factor in the endotoxin-treated conscious dog

Shock

Volumn 5, Issue 5, 1996, Pages 344-348

  McGuinness, Owen P ^a   Lacy, D Brooks ^a   Ejiofor, Joseph ^a   Bagby, Gregory G ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; DOG; FEMALE; LIVER; MALE; METABOLISM; PATHOLOGY; SEPTIC SHOCK;

ANIMALS; DOGS; FEMALE; LIPOPOLYSACCHARIDES; LIVER; MALE; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030133659     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199605000-00006     Document Type: Article

References (23)

1. LeMay DR, LeMay LG, D' Alecy LG, Kluger MJ: Plasma profiles of IL-6 and TNF with fever-inducing doses of lipopolysaccharide in dogs. Am J Physiol 259:R126-R132, 1990.
2. Fong YM, Marano MA, Moldawer LL, et al: The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 85:1896-1904, 1990.
3. Feuerstein G, Hallenbeck JM, Vanatta B, Rabinovici R, Perera PY, Vogel SN: Effects of Gram-negative endotoxin on levels of serum corticosterone, TNFα, circulating blood cells, and the survival of rats. Circ Shock 30:265-278, 1990.
4. Hoffman R, Grewe M, Estler HC, Schulze-Specking A, Decker K: Detection of different TNF-α-mRNA-synthesizing cells in the LPS perfused rat liver by non-radioactive in situ hybridization. Knook DL, Wisse E (eds): Cells of the Hepatic Sinusiod. Leiden: The Netherlands, Kupffer Cell Foundation, 1993, pp 17-20.
5. Ulich TR, Guo K, Del Castillo J: Endotoxin-induced cytokine gene expression in vivo. I. Expression of tumor necrosis factor mRNA in visceral organs under physiologic conditions and during endotoxemia. Am J Pathol 134:11-14, 1989.
6. Bautista AP, Skrepnik N, Niesman MR, Bagby GJ: Elimination of macrophages by liposome-encapsulated dichloromethylene diphosphonate suppresses the endotoxin-induced priming of Kupffer cells. J Leukocyte Biol 55:321-327, 1995.
7. Matuschak GM, Munoz C, Epperly NA, et al: TNF-α and IL-6 expression in perfused rat liver after intraportal candidemia vs. E. coli or S. aureus bacteremia. Am J Physiol 267:R446-R454, 1994.
8. Liao J, Keiser JA, Scales WE, Kunkel SL, Kluger MJ: Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am J Physiol 268:R896-R901, 1995.
9. Tran-Thi T, Weinhold L, Weinstock C, et al: Production of tumor necrosis factor-α, interleukin-1 and interleukin-6 in the perfused rat liver. Eur Cytokine Net 4:363-370, 1993.
10. Giroir B, Johnson JH, Brown T, Allen GL, Beutler B: Tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 90:693-698, 1992.
11. Cirelli RA, Carey LA, Fisher JK, et al: Endotoxin infusion in anesthetized sheep is associated with intrapulmonary sequestration of leukocytes that immunohistochemically express tumor necrosis factor-α. J Leukocyte Biol 57:820-826, 1995.
12. McGuinness OP, Lacy DB, Anderson J: Effect of acute glucagon removal on metabolic response to infection in conscious dog. Am J Physiol 268: E92-E99, 1995.
13. Leevy CM, Mendenhall CL, Lesko W, Howard MM: Estimation of hepatic blood flow with indocyanine green. J Clin Invest 41:1169-1179, 1962.
14. Espevik T, Nissen-Meyer J: A highly sensitive line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 95:99-105, 1986.
15. Hansen MB, Nielsen SE, Berg K: Re-examination and further development of a precise and rapid method for measuring cell growth/cell kill. J Immunol Methods 119:203-210, 1986.
16. Bocci V, Pacini A, Pessina GP, Maioli E, Naldini A: Studies on tumor necrosis factor (TNF)-I: Phamacokinetics of human recombinant TNF in rabbits and monkeys after intravenous administration. Gen Pharmacol 18:343-346, 1987.
17. Ferrannini E, Cobelli C: The kinetics of insulin in man. I. General aspects. Diabetes Metab Rev 3:335-363, 1987.
18. Bocci V: Interleukins: Clinical pharmacokinetics and practical implications. Clin Pharmacokinet 21:274-284, 1991.
19. McGuinness OP, Spitzer JJ: Hepatic glycerol kinetics following E. coli endotoxin administration. Am J Physiol 247:R687-R692, 1984.
20. Mathison JC, Ulevitch RJ: The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 123:2133-2143, 1979.
21. Nelson S, Bagby GJ, Blainton BG, Wilson LA, Thompson JJ: Compartmentalization of intra-alveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis 159:189-194, 1989.
22. Kus B, Sersa G, Novakovic S, Urbancic J, Stalc A: Modification of TNF-α pharmacokinetics in SA-1 tumor-bearing mice. Int J Cancer 55:110-114, 1993.
23. Granowitz EV, Santos AA, Poutsiaka DD, et al: Production of interleukin-1 receptor antagonist during endotoxemia. Lancet 338:1423-1424, 1991.